Gerard Ber

CIK 1762144 · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.83M

Companies

3

Total Filings

24

Lifetime Open-Market Net

-$1.58M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LNTH Director 27,118 $104.52 $2.83M -$1.57M 15 2026-06-03
Y-mAbs Therapeutics, Inc. (YMAB) Delisted Director 1,608 $8.61 $13.8K -$8.7K 6 2024-06-11
PROGENICS PHARMACEUTICALS INC (PGNX) Delisted Director $0 2 2019-12-17

Recent Filings · Page 2 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-07-19 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Grant (A) $0 EDGAR
2022-05-12 LNTH Sell (S) −1,277 -$74.3K EDGAR
2022-05-12 LNTH Grant (A) $0 EDGAR
2022-05-10 LNTH Grant (A) +2,180 $0 EDGAR
2021-06-14 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Grant (A) $0 EDGAR
2021-05-12 LNTH Grant (A) +8,513 $0 EDGAR
2020-10-05 LNTH Grant (A) +1,065 $0 EDGAR
2020-08-12 LNTH Grant (A) +741 $0 EDGAR
2020-06-24 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Grant (A) $0 EDGAR
2020-06-23 LNTH Grant (A) +21,481 $0 EDGAR
Showing 1120 of 24
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.